3 quality ASX shares I'd buy while everyone else is nervous

Here's three ASX quality shares worth buying while fear grips the market

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) slipped again on Monday after US-Iran peace talks collapsed over the weekend. Oil prices surged back above US$100 a barrel, reigniting inflation concerns across global markets.

The benchmark index finished the session down 0.39% to 8,926 points as investors moved away from risk across most sectors.

While that kind of geopolitical shock can feel uncomfortable in the moment, these are often the periods when long-term opportunities start to appear.

When fear pushes quality businesses lower alongside everything else, I prefer to focus on proven ASX names with durable earnings, strong market positions, and long growth runways.

Here are three quality ASX shares I would be happy to buy while sentiment remains fragile.

A trendy woman wearing sunglasses splashes cash notes from her hands.

Image source: Getty Images

Xero Ltd (ASX: XRO)

Xero is still one of the highest-quality software businesses on the ASX.

The company provides cloud accounting, payroll, invoicing, payments, and small business finance tools for SMEs and accountants. This has made Xero deeply embedded in the day-to-day operations of businesses across Australia, New Zealand, the UK, and increasingly the US.

That stickiness continues to show up in the numbers. In H1 FY26, Xero delivered revenue of roughly $1.2 billion, adjusted EBITDA of $351 million, and operating cash flow of $321.1 million, while continuing to grow subscriber numbers and average revenue per user.

Its scale, pricing power, and growing payments ecosystem give it multiple levers for long-term earnings growth.

If the broader market weakness pushes premium tech valuations lower, this is exactly the sort of proven software compounder I want to keep buying.

CSL Ltd (ASX: CSL)

CSL remains one of the ASX's clearest examples of a global defensive growth business.

The company earns most of its money from plasma therapies through CSL Behring, vaccines through Seqirus, and iron deficiency and kidney products through CSL Vifor. These are essential healthcare products with demand drivers that are far less sensitive to geopolitical headlines.

Its latest half-year result showed NPATA of US$1.9 billion, while management maintained FY26 guidance for 2% to 3% revenue growth and 4% to 7% NPATA growth.

Plasma margin recovery also still has room to play out, alongside cost savings from the broader operational simplification program.

That gives the business multiple earnings drivers even if the market stays nervous.

WiseTech Global Ltd (ASX: WTC)

WiseTech is a global logistics software leader best known for its CargoWise platform. It helps freight forwarders, customs brokers, warehouses, and supply chain operators manage complex global trade workflows.

What makes the business so powerful is how deeply integrated that software becomes once customers are onboarded.

Its most recent half-year result showed CargoWise revenue up 12% to $372.4 million, customer attrition below 1%, and group gross profit rising 61% to $529.9 million following the e2open acquisition.

That combination of high retention, recurring revenue, and global trade digitisation still gives WiseTech a very long runway.

If fear around the Middle East continues dragging high-multiple growth stocks lower, this is exactly the kind of business where I'd be happy adding on weakness.

Foolish takeaway

Broad market fear often creates the best opportunities in high-quality businesses.

For me, Xero, CSL, and WiseTech all fit that description. They are proven compounders with strong market positions, recurring earnings, and stable growth outlooks.

While everyone else is focused on geopolitical noise, I'd be looking closely at whether this pullback is offering a better long-term entry point.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Rival hands reaching upward for a company trophy or prize.
Opinions

Up 214% in 5 years! Is this still a top Australian stock to buy?

This business has done extremely well. Is it still a buy?

Read more »

Man holding fifty Australian Dollar banknotes in his hands, symbolising dividends.
Opinions

197,469 shares of this high-yield ASX dividend stock pays an income equal to the Age Pension

This stock is one of my favourite options for passive income.

Read more »

A man peers out from a high collared jacket with just his eyes and nose visible amid a swirling snowstorm.
Opinions

2 ASX shares I'd buy this July

July may be cold, but I think these shares are looking hot.

Read more »

Smiling teenager boy and laughing girls show off their balancing skills by walking in a row on a wall in the autumnal sunny city park.
Opinions

3 ASX shares I'd buy and hold for my kids

These are my top picks for investors who want ASX shares to buy and hold for decades.

Read more »

Warren Buffett
Exchange-Traded Funds (ETFs)

I think this Buffett-inspired ASX ETF is in the buy zone right now

This Buffett-inspired ETF is looking cheap.

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Opinions

Why I just invested $3,000 in these 3 ASX shares

These businesses have a lot to offer my portfolio. I bought them because...

Read more »

Rocket takes off from the hand of a businessman.
IPOs

What's gone wrong with the SpaceX IPO?

SpaceX rocketed on the IPO, but its flight path has since stalled.

Read more »

A female athlete in green spandex leaps from one cliff edge to another.
Opinions

A rare buying opportunity in 1 of Australia's top shares?

This stock could provide delicious returns.

Read more »